JP2005512074A5 - - Google Patents

Download PDF

Info

Publication number
JP2005512074A5
JP2005512074A5 JP2003551313A JP2003551313A JP2005512074A5 JP 2005512074 A5 JP2005512074 A5 JP 2005512074A5 JP 2003551313 A JP2003551313 A JP 2003551313A JP 2003551313 A JP2003551313 A JP 2003551313A JP 2005512074 A5 JP2005512074 A5 JP 2005512074A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003551313A
Other versions
JP2005512074A (ja
Filing date
Publication date
Priority claimed from US10/010,005 external-priority patent/US6927071B2/en
Application filed filed Critical
Publication of JP2005512074A publication Critical patent/JP2005512074A/ja
Publication of JP2005512074A5 publication Critical patent/JP2005512074A5/ja
Pending legal-status Critical Current

Links

JP2003551313A 2001-12-07 2002-12-03 血清または血漿存在下でのラテックス微粒子の非特異的集合を低減する方法 Pending JP2005512074A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/010,005 US6927071B2 (en) 2001-12-07 2001-12-07 Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma
PCT/US2002/038393 WO2003050292A2 (en) 2001-12-07 2002-12-03 Method for reducing non-specific aggregation of latex microparticles in the presence of serum or plasma

Publications (2)

Publication Number Publication Date
JP2005512074A JP2005512074A (ja) 2005-04-28
JP2005512074A5 true JP2005512074A5 (ja) 2006-02-02

Family

ID=21743264

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003551313A Pending JP2005512074A (ja) 2001-12-07 2002-12-03 血清または血漿存在下でのラテックス微粒子の非特異的集合を低減する方法

Country Status (4)

Country Link
US (1) US6927071B2 (ja)
EP (1) EP1463947A4 (ja)
JP (1) JP2005512074A (ja)
WO (1) WO2003050292A2 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777246B2 (en) * 2001-12-18 2004-08-17 Roche Diagnostics Gmbh Tertiary amine compounds for use in immunoassays
JP4503334B2 (ja) * 2004-03-31 2010-07-14 デンカ生研株式会社 免疫測定に供する検体浮遊液調製用媒体組成物及びそれを用いる免疫測定方法
US7935541B2 (en) 2007-09-28 2011-05-03 Fujifilm Corporation Immunochromatography method using fragmented antibody
JP5435878B2 (ja) * 2008-02-12 2014-03-05 富士フイルム株式会社 断片化抗体を標識物質に固定した標識粒子
US20220196640A1 (en) * 2019-05-20 2022-06-23 Siemens Healthcare Diagnostics Inc. Methods for detecting aberrant results caused by incomplete delivery of a polyhapten reagent in immunoassays

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310508A (en) * 1979-06-19 1982-01-12 Siber George Diagnostic test and reagent therefor
AU543007B2 (en) 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
US4713350A (en) * 1983-10-24 1987-12-15 Technicon Instruments Corporation Hydrophilic assay reagent containing one member of specific binding pair
US4536478A (en) 1984-04-05 1985-08-20 Seragan Diagnostics, Inc. Method for reducing non-specific interferences in agglutination immunoassays
JPS60261591A (ja) * 1984-06-07 1985-12-24 Hitachi Plant Eng & Constr Co Ltd 廃水の処理剤及びその製造方法
US4703001A (en) 1985-10-23 1987-10-27 Synbiotics, Corporation Immunoassay for the detection of serum analytes using pH dependent chastropic acids
US4917685A (en) * 1986-05-16 1990-04-17 International Minerals & Chem. Corp. Delivery device for the administration of stabilized growth promoting hormones
US4847209A (en) 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
JPH03151348A (ja) * 1989-11-08 1991-06-27 Showa Shell Sekiyu Kk 光学活性含弗素‐3‐ヒドロキシ酪酸エステル類およびその製造方法
US5326692B1 (en) * 1992-05-13 1996-04-30 Molecular Probes Inc Fluorescent microparticles with controllable enhanced stokes shift
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
DE4343479A1 (de) * 1993-12-21 1995-06-22 Boehringer Mannheim Gmbh Acylierte Proteinaggregate und deren Verwendung zur Entstörung von Immunoassays
US5506151A (en) 1994-02-09 1996-04-09 Mitsubishi Kasei Corporation Non-specific reaction suppressor
US5486479A (en) 1994-05-02 1996-01-23 Mitsubishi Chemical Corporation Buffer for immunoassay, kit including same and immunoassay method using said buffer
DE69527877T2 (de) * 1994-04-29 2003-04-30 Seradyn Inc Mikropartikel-Immunoassayreagentien, empfindliche und spezifische Immunoassayreagentien und Immunoassaymethode
JP4896347B2 (ja) * 2000-06-30 2012-03-14 協和メデックス株式会社 不溶性担体粒子比濁免疫測定用試薬

Similar Documents

Publication Publication Date Title
BE2019C547I2 (ja)
BE2019C510I2 (ja)
BE2018C021I2 (ja)
BE2017C049I2 (ja)
BE2017C005I2 (ja)
BE2016C069I2 (ja)
BE2016C040I2 (ja)
BE2016C013I2 (ja)
BE2018C018I2 (ja)
BE2016C002I2 (ja)
BE2015C078I2 (ja)
BE2015C017I2 (ja)
BE2014C053I2 (ja)
BE2014C051I2 (ja)
BE2014C041I2 (ja)
BE2014C030I2 (ja)
BE2014C016I2 (ja)
BE2014C015I2 (ja)
BE2013C063I2 (ja)
BE2013C039I2 (ja)
BE2011C038I2 (ja)
BRPI0302144B1 (ja)
BRPI0215435A2 (ja)
BE2013C046I2 (ja)
JP2003244465A5 (ja)